PP
CELG

Paloma Partners’s Celgene Corp CELG Stock Holding History

Paloma Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6,700
Closed -$429K – 2116
2018
Q4 		$429K Buy
+6,700
New +$495K 0.01% 731
2018
Q1 		– Sell
-19,600
Closed -$2.04M – 2456
2017
Q4 		$2.04M Hold
19,600
– – 0.03% 655
2017
Q3 		$2.86M Sell
19,600
-59,500
-75% -$8.1M 0.04% 527
2017
Q2 		$10.3M Buy
79,100
+22,500
+40% +$2.76M 0.12% 130
2017
Q1 		$7.04M Buy
56,600
+15,500
+38% +$1.85M 0.08% 197
2016
Q4 		$4.76M Buy
41,100
+17,100
+71% +$1.9M 0.05% 270
2016
Q3 		$2.51M Hold
24,000
– – 0.03% 440
2016
Q2 		$2.37M Buy
24,000
+16,800
+233% +$1.74M 0.03% 628
2016
Q1 		$721K Hold
7,200
– – 0.01% 1096
2015
Q4 		$862K Hold
7,200
– – 0.02% 726
2015
Q3 		$779K Sell
7,200
-95,300
-93% -$11.8M 0.02% 790
2015
Q2 		$11.9M Buy
+102,500
New +$11.7M 0.23% 92

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Paloma Partners's CELG Position: Q4 2019 in Review

Paloma Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 69,900 shares — an estimated $6.94M sold.

Paloma Partners first reported a position in CELG in Q2 2013 and held it in 24 quarters. The position peaked at $14.7M in Q1 2016. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Paloma Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Paloma Partners sold 69,900 Celgene Corp shares in Q4 2019, an estimated $6.94M.
  • Paloma Partners first reported a position in Celgene Corp in Q2 2013 and held it in 24 quarters.
  • Paloma Partners's Celgene Corp position peaked at $14.7M in Q1 2016.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Paloma Partners's 13F filing for Q4 2019, filed 14 Feb 2020.